Skip to content

Evaluation of effect of thyroid hormone therapy on prognosis of patients with traumatic brain injury

Evaluation of effect of thyroid hormone therapy on recovery of patients with moderate to severe traumatic brain injury at Emtiaz’s hospital of Shiraz: a randomized clinical trial

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20130310012776N6
Enrollment
266
Registered
2021-09-30
Start date
2021-09-23
Completion date
Unknown
Last updated
2021-11-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diffuse traumatic brain injury. Diffuse traumatic brain injury

Interventions

Intervention 1: Intervention group: Patients with Pure moderate-to-severe TBI (GCS: motor score < 6) and low normal TFT profile: T3 & T4 in first 25% of normal range + normal range of TSH, will receiv

Sponsors

Vice chancellor of research. Shiraz University of medical sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
16 Years to 65 Years

Inclusion criteria

Inclusion criteria: Pure moderate-to-severe TBI (GCS: motor score < 6) Low normal TFT profile: T3 & T4 in first 25% of normal range normal range of TSH

Exclusion criteria

Exclusion criteria: Mild traumatic brain injury Patients with a pituitary abnormality on pituitary imaging Patients who were unwilling to participate in the study or had not completed their investigations History of Hyperthyroidism or hypothyroidism History of thyroid hormone therapy History of thyroid surgery Glasgow coma scale=3 & Glasgow coma scale=4 with fixed pupils

Design outcomes

Primary

MeasureTime frame
ICU length of stay. Timepoint: Since the time of trauma to discharge from the hospital. Method of measurement: Day.

Secondary

MeasureTime frame
Glasgow outcome scale extended. Timepoint: Three & six month after traumatic brain injury. Method of measurement: Glasgow outcome scale extended.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHosseinali Khalili

Shiraz University of Medical Sciences

khalili_h@sums.ac.ir+98 71 3625 4206

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026